BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33785065)

  • 1. Amyloid pathology arrangements in Alzheimer's disease brains modulate in vivo seeding capability.
    Duran-Aniotz C; Moreno-Gonzalez I; Gamez N; Perez-Urrutia N; Vegas-Gomez L; Soto C; Morales R
    Acta Neuropathol Commun; 2021 Mar; 9(1):56. PubMed ID: 33785065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer's Disease.
    Xu G; Fromholt S; Borchelt DR
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer's disease.
    Morales R; Duran-Aniotz C; Bravo-Alegria J; Estrada LD; Shahnawaz M; Hu PP; Kramm C; Morales-Scheihing D; Urayama A; Soto C
    Acta Neuropathol Commun; 2020 Dec; 8(1):213. PubMed ID: 33287898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
    Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
    Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.
    Watts JC; Condello C; Stöhr J; Oehler A; Lee J; DeArmond SJ; Lannfelt L; Ingelsson M; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10323-8. PubMed ID: 24982139
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
    Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
    Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling Alzheimer-amyloidosis models by seeding.
    Ulm BS; Borchelt DR; Moore BD
    Mol Neurodegener; 2021 Feb; 16(1):8. PubMed ID: 33588898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
    Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
    Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
    Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.
    Ye L; Rasmussen J; Kaeser SA; Marzesco AM; Obermüller U; Mahler J; Schelle J; Odenthal J; Krüger C; Fritschi SK; Walker LC; Staufenbiel M; Baumann F; Jucker M
    EMBO Rep; 2017 Sep; 18(9):1536-1544. PubMed ID: 28701326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization.
    Pedrero-Prieto CM; Flores-Cuadrado A; Saiz-Sánchez D; Úbeda-Bañón I; Frontiñán-Rubio J; Alcaín FJ; Mateos-Hernández L; de la Fuente J; Durán-Prado M; Villar M; Martínez-Marcos A; Peinado JR
    Alzheimers Res Ther; 2019 Jun; 11(1):56. PubMed ID: 31253170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brains from non-Alzheimer's individuals containing amyloid deposits accelerate Aβ deposition in vivo.
    Duran-Aniotz C; Morales R; Moreno-Gonzalez I; Hu PP; Soto C
    Acta Neuropathol Commun; 2013 Nov; 1(1):76. PubMed ID: 24252208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
    Kane MD; Lipinski WJ; Callahan MJ; Bian F; Durham RA; Schwarz RD; Roher AE; Walker LC
    J Neurosci; 2000 May; 20(10):3606-11. PubMed ID: 10804202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Aβ peptides acquire prion-like properties in the brain.
    Xiao X; Cali I; Yuan J; Cracco L; Curtiss P; Zeng L; Abouelsaad M; Gazgalis D; Wang GX; Kong Q; Fujioka H; Puoti G; Zou WQ
    Oncotarget; 2015 Jan; 6(2):642-50. PubMed ID: 25460507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.